How has been the historical performance of Abbott India?

Answer:Abbott India's historical performance shows a consistent growth trajectory in net sales and profitability over the years.

Breakdown:
Abbott India's net sales have steadily increased from INR 3,678.60 crore in March 2019 to INR 6,409.15 crore in March 2025, reflecting a strong upward trend. The total operating income has followed a similar pattern, rising from INR 3,678.60 crore to INR 6,409.15 crore during the same period. The operating profit (PBDIT) has also seen significant growth, climbing from INR 718.02 crore in March 2019 to INR 1,970.18 crore in March 2025, indicating improved operational efficiency. Profit before tax has increased from INR 698.85 crore to INR 1,886.95 crore, while profit after tax has risen from INR 450.33 crore to INR 1,414.44 crore, showcasing robust profitability. The earnings per share (EPS) have grown from INR 211.92 to INR 665.62, reflecting enhanced shareholder value. On the balance sheet, total assets have expanded from INR 3,532.41 crore to INR 5,902.35 crore, with total liabilities also increasing, but remaining manageable at zero debt. Cash flow from operating activities has shown a positive trend, reaching INR 1,011 crore in March 2025, while the closing cash and cash equivalents have improved to INR 560 crore, indicating a solid liquidity position. Overall, Abbott India has demonstrated strong financial performance and growth across key metrics over the years.